TipRanks
Medexus Pharmaceuticals Inc (DE:P731)
FRANKFURT:P731
Germany Market
P731
Medexus Pharmaceuticals Inc
RESEARCH TOOLSreports

Medexus Pharmaceuticals Inc (P731) Ratios

2 Followers

Medexus Pharmaceuticals Inc Ratios

DE:P731's free cash flow for Q1 2027 was C$0.56. For the 2027 fiscal year, DE:P731's free cash flow was decreased by C$ and operating cash flow was C$0.07. See a summary of the company’s cash flow.
Ratios
TTM
Mar 26Mar 24Mar 23Mar 22
Liquidity Ratios
Current Ratio
 1.30 1.19 1.09 0.65 0.82
Quick Ratio
 0.64 0.57 0.63 0.44 0.46
Cash Ratio
 0.12 0.12 0.08 0.16 0.21
Solvency Ratio
 0.08 0.07 0.04 0.05 0.03
Operating Cash Flow Ratio
 0.31 0.35 0.28 -0.01 -0.02
Short-Term Operating Cash Flow Coverage
 5.79 8.53 1.19 -0.03 -0.06
Net Current Asset Value
C$ -35.08M$ -34.51M$ -52.91M$ -114.73M$ -102.71M
Leverage Ratios
Debt-to-Assets Ratio
 0.18 0.15 0.32 0.59 0.39
Debt-to-Equity Ratio
 0.55 0.45 1.65 4.22 3.08
Debt-to-Capital Ratio
 0.35 0.31 0.62 0.81 0.76
Long-Term Debt-to-Capital Ratio
 0.33 0.29 0.53 0.54 0.69
Financial Leverage Ratio
 2.96 3.01 5.14 7.19 7.83
Debt Service Coverage Ratio
 2.22 1.69 0.65 0.31 0.52
Interest Coverage Ratio
 2.06 1.12 0.81 0.56 -1.23
Debt to Market Cap
 0.22 0.22 1.38 2.64 0.95
Interest Debt Per Share
 0.93 0.85 2.83 5.42 3.45
Net Debt to EBITDA
 1.64 1.24 2.32 4.77 2.79
Profitability Margins
Gross Profit Margin
54.73%54.78%52.64%55.54%49.45%
EBIT Margin
2.83%2.95%11.91%7.92%10.96%
EBITDA Margin
12.30%12.75%17.05%14.93%19.77%
Operating Profit Margin
6.64%5.87%9.55%7.04%-19.55%
Pretax Profit Margin
-2.31%-2.29%0.09%-4.66%-4.98%
Net Profit Margin
-2.29%-2.41%-0.19%1.13%-3.75%
Continuous Operations Profit Margin
-2.29%-2.41%-0.19%1.13%-3.75%
Net Income Per EBT
99.21%105.28%-201.89%-24.22%75.37%
EBT Per EBIT
-34.70%-38.97%0.98%-66.21%25.47%
Return on Assets (ROA)
-1.67%-1.63%-0.14%0.76%-2.07%
Return on Equity (ROE)
-4.69%-4.89%-0.71%5.44%-16.18%
Return on Capital Employed (ROCE)
7.09%6.23%12.06%15.70%-18.96%
Return on Invested Capital (ROIC)
6.86%6.08%-20.71%-1.74%-11.55%
Return on Tangible Assets
-3.37%-3.20%-0.26%1.51%-5.54%
Earnings Yield
-2.01%-2.37%-0.60%3.82%-4.71%
Efficiency Ratios
Receivables Turnover
 7.90 6.69 4.70 3.64 5.32
Payables Turnover
 1.23 5.46 6.91 4.73 2.57
Inventory Turnover
 1.57 1.35 1.74 2.10 1.82
Fixed Asset Turnover
 278.15 235.38 145.31 120.24 62.82
Asset Turnover
 0.73 0.67 0.73 0.67 0.55
Working Capital Turnover Ratio
 8.64 -30.40 -6.73 -4.25 20.18
Cash Conversion Cycle
 -18.79 258.36 234.53 196.65 127.78
Days of Sales Outstanding
 46.18 54.59 77.58 100.27 68.56
Days of Inventory Outstanding
 232.74 270.57 209.78 173.53 200.99
Days of Payables Outstanding
 297.71 66.81 52.83 77.15 141.77
Operating Cycle
 278.92 325.16 287.36 273.80 269.55
Cash Flow Ratios
Operating Cash Flow Per Share
 0.43 0.58 0.84 -0.07 -0.06
Free Cash Flow Per Share
 -0.04 0.12 0.83 -0.09 -0.46
CapEx Per Share
 0.47 0.47 0.01 0.02 0.40
Free Cash Flow to Operating Cash Flow
 -0.09 0.20 0.99 1.25 7.54
Dividend Paid and CapEx Coverage Ratio
 0.92 1.25 70.35 -3.99 -0.15
Capital Expenditure Coverage Ratio
 0.92 1.25 70.35 -3.99 -0.15
Operating Cash Flow Coverage Ratio
 0.53 0.85 0.38 -0.02 -0.02
Operating Cash Flow to Sales Ratio
 0.13 0.19 0.17 -0.01 -0.02
Free Cash Flow Yield
-1.04%3.69%51.33%-5.65%-14.56%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -48.36 -44.57 -167.93 26.18 -21.22
Price-to-Sales (P/S) Ratio
 1.13 1.02 0.32 0.30 0.80
Price-to-Book (P/B) Ratio
 2.45 2.06 1.19 1.42 3.43
Price-to-Free Cash Flow (P/FCF) Ratio
 -96.40 27.10 1.95 -17.70 -6.87
Price-to-Operating Cash Flow Ratio
 8.49 5.34 1.92 -22.13 -51.77
Price-to-Earnings Growth (PEG) Ratio
 -0.59 0.25 1.50 -0.18 0.23
Price-to-Fair Value
 2.45 2.06 1.19 1.42 3.43
Enterprise Value Multiple
 10.84 9.21 4.18 6.76 6.82
Enterprise Value
 137.68M 116.57M 80.58M 109.02M 103.42M
EV to EBITDA
 10.84 9.21 4.18 6.76 6.82
EV to Sales
 1.33 1.17 0.71 1.01 1.35
EV to Free Cash Flow
 -113.61 31.34 4.37 -60.36 -11.63
EV to Operating Cash Flow
 9.95 6.18 4.31 -75.50 -87.65
Tangible Book Value Per Share
 -0.75 -0.73 -1.98 -5.36 -5.13
Shareholders’ Equity Per Share
 1.51 1.52 1.36 1.12 0.91
Tax and Other Ratios
Effective Tax Rate
 <0.01 -0.05 3.02 1.24 0.25
Revenue Per Share
 3.25 3.07 5.06 5.41 3.94
Net Income Per Share
 -0.07 -0.07 >-0.01 0.06 -0.15
Tax Burden
 0.99 1.05 -2.02 -0.24 0.75
Interest Burden
 -0.81 -0.78 <0.01 -0.59 -0.45
Research & Development to Revenue
 0.07 0.09 0.07 0.03 0.10
SG&A to Revenue
 0.39 0.40 0.25 0.34 0.38
Stock-Based Compensation to Revenue
 <0.01 <0.01 <0.01 0.01 0.02
Income Quality
 -5.81 -7.88 -87.45 -1.18 0.41